CN114305659B - High-frequency bipolar unrecoverable electroporation system - Google Patents

High-frequency bipolar unrecoverable electroporation system Download PDF

Info

Publication number
CN114305659B
CN114305659B CN202111607045.1A CN202111607045A CN114305659B CN 114305659 B CN114305659 B CN 114305659B CN 202111607045 A CN202111607045 A CN 202111607045A CN 114305659 B CN114305659 B CN 114305659B
Authority
CN
China
Prior art keywords
cell
pulse
unit
parameter
adjusting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202111607045.1A
Other languages
Chinese (zh)
Other versions
CN114305659A (en
Inventor
张建浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Intelligent Health Co ltd
Original Assignee
Tianjin Intelligent Health Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Intelligent Health Co ltd filed Critical Tianjin Intelligent Health Co ltd
Priority to CN202111607045.1A priority Critical patent/CN114305659B/en
Publication of CN114305659A publication Critical patent/CN114305659A/en
Application granted granted Critical
Publication of CN114305659B publication Critical patent/CN114305659B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention provides a high-frequency bipolar unrecoverable electroporation system, which comprises a bipolar electroporation module, a data acquisition module and a perforation adjustment module; the bipolar perforation module comprises a bipolar pulse generator and a pulse control unit, the pulse control unit is respectively connected with the perforation adjusting module and the bipolar pulse generator, and the pulse control unit is used for receiving an adjusting instruction of the perforation adjusting module and controlling the operation of the bipolar pulse generator according to the adjusting instruction; the data acquisition module comprises a cell characteristic pre-acquisition unit, a pulse parameter acquisition unit and a cell therapy parameter acquisition unit; the cell characteristic pre-acquisition unit is used for acquiring cell basic characteristics before treatment, and pulse output parameters can be transformed based on the basic characteristics of different cell levels and treatment effects so as to solve the problem of poor high-frequency perforation treatment effect in the prior art.

Description

High-frequency bipolar unrecoverable electroporation system
Technical Field
The invention relates to the technical field of pulse perforation treatment, in particular to a high-frequency bipolar unrecoverable electroporation system.
Background
The high-frequency bipolar pulse in the high-frequency bipolar unrecoverable electroporation system outputs bipolar pulses by using the control module, and output parameters of the bipolar pulses can be adjusted by using the control module, wherein the pulses generally refer to electric shock which is applied frequently in the electronic technology and has transient fluctuation like pulses, and the application of pulsed electric fields in the existing medical field is more and more extensive, especially the application of ablation and perforation on cells is more and more extensive.
In the prior art, in the application of high-frequency pulse perforation therapy, therapy is usually performed based on specific preset perforation parameters, because cells have different levels, and requirements of each level on the perforation parameters are different, it is difficult to perform targeted therapy according to the basic characteristics of the cells in the prior art, and the perforation process cannot be accurately judged, so that the perforation therapy effect is weak, and the therapy effect is poor.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a high-frequency bipolar unrecoverable electroporation system which can transform pulse output parameters based on the basic characteristics of different cell levels and the treatment effect so as to solve the problem of poor high-frequency electroporation treatment effect in the prior art.
In order to achieve the purpose, the invention is realized by the following technical scheme: the high-frequency bipolar unrecoverable electroporation system comprises a bipolar electroporation module, a data acquisition module and a perforation adjustment module;
the bipolar perforation module comprises a bipolar pulse generator and a pulse control unit, the pulse control unit is respectively connected with the perforation adjusting module and the bipolar pulse generator, and the pulse control unit is used for receiving an adjusting instruction of the perforation adjusting module and controlling the operation of the bipolar pulse generator according to the adjusting instruction;
the data acquisition module comprises a cell characteristic pre-acquisition unit, a pulse parameter acquisition unit and a cell therapy parameter acquisition unit; the cell characteristic pre-acquisition unit is used for acquiring cell basic characteristics before treatment, the pulse parameter acquisition unit is used for acquiring output parameters of a pulse generator in the treatment process, and the cell treatment parameter acquisition unit is used for acquiring cell treatment characteristics in the treatment process;
the perforation adjusting module comprises a cell characteristic preprocessing unit, a cell change processing unit and an adjusting unit, wherein the cell characteristic preprocessing unit is respectively connected with the pulse control unit and the cell characteristic pre-collecting unit and is used for processing cell basic characteristics to obtain pulse basic parameters and outputting the obtained pulse basic parameters to the pulse control unit;
the cell change processing unit is connected with the cell characteristic pre-acquisition unit and the cell treatment parameter acquisition unit and is used for processing the acquired cell basic characteristics and cell treatment characteristics and obtaining a cell change result;
the adjusting unit is connected with the cell change processing unit and the pulse parameter acquiring unit, and is used for processing the cell change result and the output parameter of the pulse generator to obtain an adjusting result, converting the adjusting result into an adjusting instruction and outputting the adjusting instruction to the pulse control unit.
Further, the basic characteristics of the cells collected by the cell characteristic pre-collecting unit comprise cell membrane thickness, cytoplasm thickness, cell nucleus membrane thickness and cell nucleus cytoplasm thickness;
the output parameters of the pulse generator collected by the pulse parameter acquisition unit comprise pulse width;
the cell therapy characteristics in the therapy process acquired by the cell therapy parameter acquisition unit comprise a cell membrane potential value, cell membrane conductivity and a perforation aperture.
Further, the cell characteristic preprocessing unit is configured with a cell characteristic preprocessing strategy, which comprises: substituting the cell membrane thickness, the cytoplasm thickness, the cell nucleus membrane thickness and the cell nucleus cytoplasm thickness into a pulse basic formula to obtain a pulse basic parameter value;
and outputting the pulse basic parameter value to a pulse control unit.
Further, the pulse basis formula is configured to:
Mjc=(k1×Hxm×2+k2×Hxz×2+k3×Hxhm×2+k4×Hxhz) α (ii) a Wherein Mjc is a pulse basic parameter value, Hxm is a cell membrane thickness, Hxz is a cytoplasm thickness, Hxhm is a cell nucleus membrane thickness, Hxhz is a cell nucleus cytoplasm thickness, k1 is a cell membrane parameter proportion value, k2 is a cytoplasm parameter proportion value, k3 is a cell nucleus membrane parameter proportion value, k4 is a cell nucleus cytoplasm parameter proportion value, and alpha is a cell basic characteristic pulse conversion coefficient.
Further, the cell change processing unit is configured with a cell change processing strategy comprising: acquiring data acquired by the cell therapy parameter acquisition unit once every first change time;
introducing the obtained cell membrane potential value, cell membrane conductivity and perforation aperture of the first change times, and cell membrane thickness, cytoplasm thickness, cell nucleus membrane thickness and cell nucleus cytoplasm thickness into a cell change formula to obtain a cell change reference value;
the cell change reference value is output to the adjustment unit.
Further, the cellular variation formula is configured to:
Figure BDA0003434314950000031
wherein Cbh is a cell change reference value, i is a first change number, a Dxm1 value Dxmi is a cell membrane potential value obtained from the first time within the first change number to a cell membrane potential value obtained from the ith time, Dxm1 to Dxm is a cell membrane conductivity obtained from the first time within the first change number to a cell membrane conductivity obtained from the ith time, Jc1 to Jci are a perforation aperture obtained from the first time within the first change number to a perforation aperture obtained from the ith time, l1 is a reference ratio value of the cell membrane potential value, l2 is a reference ratio value of the cell membrane conductivity, and l3 is a reference ratio value of the perforation aperture.
Further, the adjusting unit is configured with an adjusting strategy, which includes: obtaining a pulse parameter adjustment value by substituting the pulse width, the pulse basic parameter value, the cell change reference value and a pulse adjustment formula;
and outputting the pulse parameter adjustment value to a pulse control unit.
Further, the pulse adjustment formula is configured to:
Figure BDA0003434314950000041
wherein, Mct is a pulse parameter adjustment value, Mk is a pulse width, beta is a pulse conversion ratio, and lambda is a cell change compensation coefficient.
The invention has the beneficial effects that:
1. the bipolar perforation module comprises a bipolar pulse generator and a pulse control unit, the pulse control unit can receive an adjusting instruction of the perforation adjusting module and control the operation of the bipolar pulse generator according to the adjusting instruction, and the design can adjust pulse output parameters in time according to the actual treatment process and improve the convenience of adjustment and control.
2. The data acquisition module comprises a cell characteristic pre-acquisition unit, a pulse parameter acquisition unit and a cell treatment parameter acquisition unit, wherein the cell characteristic pre-acquisition unit can acquire cell basic characteristics before treatment, the pulse parameter acquisition unit can acquire output parameters of a pulse generator in the treatment process, and the cell treatment parameter acquisition unit can acquire cell treatment characteristics in the treatment process.
3. The perforation adjusting module comprises a cell characteristic preprocessing unit, a cell change processing unit and an adjusting unit, wherein the cell characteristic preprocessing unit is used for processing cell basic characteristics to obtain pulse basic parameters and outputting the obtained pulse basic parameters to a pulse control unit; the cell change processing unit can process the acquired cell basic characteristics and cell treatment characteristics to obtain a cell change result; the adjustment unit can process the cell change result and the output parameters of the pulse generator to obtain an adjustment result, and the adjustment result is converted into an adjustment instruction to be output to the pulse control unit.
Drawings
Other features, objects and advantages of the invention will become more apparent upon reading of the detailed description of non-limiting embodiments with reference to the following drawings:
FIG. 1 is a functional block diagram of the present invention;
fig. 2 is a schematic block diagram illustrating the connection of the bipolar perforation module, the data acquisition module, and the perforation adjustment module according to the present invention.
Detailed Description
In order to make the technical means, the creation characteristics, the achievement purposes and the effects of the invention easy to understand, the invention is further described with the specific embodiments.
Referring to fig. 1, the high-frequency bipolar non-recoverable electroporation system includes a bipolar electroporation module, a data acquisition module, and a perforation adjustment module.
Referring to fig. 2, the bipolar perforation module includes a bipolar pulse generator and a pulse control unit, the pulse control unit is respectively connected to the perforation adjustment module and the bipolar pulse generator, and the pulse control unit is configured to receive an adjustment instruction from the perforation adjustment module and control the operation of the bipolar pulse generator according to the adjustment instruction. The output parameters of the bipolar pulse generator can be adjusted in time by arranging the pulse control unit, so that the convenience of adjustment is improved, and the timeliness of adjustment in the treatment process is improved.
The data acquisition module comprises a cell characteristic pre-acquisition unit, a pulse parameter acquisition unit and a cell therapy parameter acquisition unit; the cell characteristic pre-acquisition unit is used for acquiring basic cell characteristics before treatment, the basic cell characteristics acquired by the cell characteristic pre-acquisition unit comprise cell membrane thickness, cytoplasm thickness, cell nucleus membrane thickness and cell nucleus cytoplasm thickness, wherein the cell membrane thickness multiplied by two + cytoplasm thickness multiplied by two + cell nucleus membrane thickness multiplied by two + cell nucleus cytoplasm thickness equals to the diameter of a cell, and the acquired parameters can be compared with the perforation aperture acquired in the subsequent treatment process for reference.
The pulse parameter acquisition unit is used for acquiring output parameters of the pulse generator in the treatment process, and the output parameters of the pulse generator acquired by the pulse parameter acquisition unit comprise pulse width which influences the perforation effect.
The cell therapy parameter acquisition unit is used for acquiring cell therapy characteristics in a therapy process; the cell therapy characteristics in the therapy process acquired by the cell therapy parameter acquisition unit comprise a cell membrane potential value, cell membrane conductivity and a perforation aperture, and the cell perforation efficiency can be reflected by the cell membrane potential value, the cell membrane conductivity and the perforation aperture.
The perforation adjusting module comprises a cell characteristic preprocessing unit, a cell change processing unit and an adjusting unit, wherein the cell characteristic preprocessing unit is respectively connected with the pulse control unit and the cell characteristic pre-collecting unit and is used for processing cell basic characteristics to obtain pulse basic parameters and outputting the obtained pulse basic parameters to the pulse control unit; the cell characteristic preprocessing unit is configured with a cell characteristic preprocessing strategy, and the cell characteristic preprocessing strategy comprises the following steps: substituting the cell membrane thickness, the cytoplasm thickness, the cell nucleus membrane thickness and the cell nucleus cytoplasm thickness into a pulse basic formula to obtain a pulse basic parameter value; and outputting the pulse basic parameter value to a pulse control unit.
The pulse basis formula is configured to:
Mjc=(k1×Hxm×2+k2×Hxz×2+k3×Hxhm×2+k4×Hxhz) α (ii) a Mjc is a pulse basic parameter value, Hxm is a cell membrane thickness, Hxz is a cell cytoplasm thickness, Hxhm is a cell nucleus membrane thickness, Hxhz is a cell nucleus cytoplasm thickness, k1 is a cell membrane parameter proportion value, k2 is a cell cytoplasm parameter proportion value, k3 is a cell nucleus membrane parameter proportion value, k4 is a cell nucleus cytoplasm parameter proportion value, and alpha is a cell basic characteristic pulse conversion coefficient, wherein k1, k2, k3, k4 and alpha are all larger than zero, the specific settings of k1, k2, k3 and k4 are preset according to the proportion of corresponding cell characteristics, and alpha can be used for presetting and adjusting the overall characteristics.
The cell change processing unit is connected with the cell characteristic pre-acquisition unit and the cell treatment parameter acquisition unit and is used for processing the acquired cell basic characteristics and cell treatment characteristics and obtaining a cell change result; the cell change processing unit is configured with a cell change processing strategy comprising: and acquiring the data acquired by the cell therapy parameter acquisition unit once every first change time.
Introducing the obtained cell membrane potential value, cell membrane conductivity and perforation aperture of the first change times, cell membrane thickness, cytoplasm thickness, cell nucleus membrane thickness and cell nucleus cytoplasm thickness into a cell change formula to obtain a cell change reference value; the cell change reference value is output to the adjustment unit. The first variation time is set according to a preset treatment period, and in particular, if the preset treatment period is set to 100 units, the first variation time can be set to 5, the first variation number is set to 4, within one treatment period, 5 first variable number of data acquisitions may be performed, and the 5 acquisitions may be respectively set as a first treatment cycle, a second treatment cycle, a third treatment cycle, a fourth treatment cycle, and a fifth treatment cycle, wherein the first treatment cycle and the second treatment cycle are anterior segment treatments, the third treatment cycle is a middle segment treatment, the fourth treatment cycle and the fifth treatment cycle are posterior segment treatments, the data acquisition is carried out on different treatment periods, the treatment effect of each treatment period can be reflected, on one hand, basic reference can be carried out on the treatment process, and on the other hand, the treatment data can be accumulated.
The cellular variation formula is configured to:
Figure BDA0003434314950000071
wherein Cbh is a cell change reference value, i is a first change time, Dxm1 value Dxmi is a cell membrane potential value obtained from the first time within the first change time to a cell membrane potential value obtained from the ith time, Ddxm1 to Ddxm are cell membrane conductivity obtained from the first time within the first change time to cell membrane conductivity obtained from the ith time, Jc1 to Jci are perforation aperture obtained from the first time within the first change time to perforation aperture obtained from the ith time, l1 is a reference ratio value of cell membrane potential values, l2 is a reference ratio value of cell membrane conductivity, and l3 is a reference ratio value of perforation aperture, wherein l1, l2 and l3 are all larger than zero, and the setting standard is set according to the cell membrane potential value, the cell membrane conductivity and the specific influence ratio of perforation aperture. In the above implementation where the treatment cycle is set to 100 units, i is set to 4.
The adjusting unit is connected with the cell change processing unit and the pulse parameter acquiring unit, and is used for processing the cell change result and the output parameter of the pulse generator to obtain an adjusting result, converting the adjusting result into an adjusting instruction and outputting the adjusting instruction to the pulse control unit.
The adjusting unit is configured with an adjusting strategy, which includes: obtaining a pulse parameter adjustment value by substituting the pulse width, the pulse basic parameter value, the cell change reference value and a pulse adjustment formula; and outputting the pulse parameter adjustment value to a pulse control unit.
The pulse adjustment formula is configured to:
Figure BDA0003434314950000081
mct is a pulse parameter adjustment value, Mk is a pulse width, beta is a pulse conversion ratio, and lambda is a cell change compensation coefficient, wherein beta and lambda are both larger than zero, beta is set according to preset standards of the pulse parameter and the pulse width, and can also be finely adjusted according to the actual treatment effect, and lambda is set according to the compensation of the amplitude of the cell change.
The working principle is as follows: in a specific treatment process, the pulse control unit can receive an adjusting instruction of the perforation adjusting module and control the operation of the bipolar pulse generator according to the adjusting instruction, the cell characteristic pre-collecting unit can collect cell basic characteristics before treatment, the pulse parameter acquiring unit can acquire output parameters of the pulse generator in the treatment process, and the cell treatment parameter acquiring unit can acquire cell treatment characteristics in the treatment process; then, the cell characteristic preprocessing unit is used for processing the cell basic characteristics to obtain pulse basic parameters, and the obtained pulse basic parameters are output to the pulse control unit; the cell change processing unit can process the acquired cell basic characteristics and cell treatment characteristics to obtain a cell change result; the cell change result and the output parameters of the pulse generator can be processed by the adjusting unit to obtain an adjusting result, the adjusting result is converted into an adjusting instruction to be output to the pulse control unit, and the bipolar pulse generator is controlled by the pulse control unit to operate again.
Finally, it should be noted that: although the present invention has been described in detail with reference to the foregoing embodiments, it should be understood by those skilled in the art that the following descriptions are only illustrative and not restrictive, and that the scope of the present invention is not limited to the above embodiments: any person skilled in the art can modify or easily conceive the technical solutions described in the foregoing embodiments or equivalent substitutes for some technical features within the technical scope of the present disclosure; such modifications, changes or substitutions do not depart from the spirit and scope of the embodiments of the present invention, and they should be construed as being included therein. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.

Claims (1)

1. The high-frequency bipolar unrecoverable electroporation system is characterized by comprising a bipolar perforation module, a data acquisition module and a perforation adjustment module;
the bipolar perforation module comprises a bipolar pulse generator and a pulse control unit, the pulse control unit is respectively connected with the perforation adjusting module and the bipolar pulse generator, and the pulse control unit is used for receiving an adjusting instruction of the perforation adjusting module and controlling the operation of the bipolar pulse generator according to the adjusting instruction;
the data acquisition module comprises a cell characteristic pre-acquisition unit, a pulse parameter acquisition unit and a cell therapy parameter acquisition unit; the cell characteristic pre-acquisition unit is used for acquiring cell basic characteristics before treatment, the pulse parameter acquisition unit is used for acquiring output parameters of a pulse generator in the treatment process, and the cell treatment parameter acquisition unit is used for acquiring cell treatment characteristics in the treatment process;
the perforation adjusting module comprises a cell characteristic preprocessing unit, a cell change processing unit and an adjusting unit, wherein the cell characteristic preprocessing unit is respectively connected with the pulse control unit and the cell characteristic pre-collecting unit and is used for processing cell basic characteristics to obtain pulse basic parameters and outputting the obtained pulse basic parameters to the pulse control unit;
the cell change processing unit is connected with the cell characteristic pre-acquisition unit and the cell treatment parameter acquisition unit and is used for processing the acquired cell basic characteristics and cell treatment characteristics and obtaining a cell change result;
the adjusting unit is connected with the cell change processing unit and the pulse parameter acquiring unit, and is used for processing the cell change result and the output parameter of the pulse generator to obtain an adjusting result, converting the adjusting result into an adjusting instruction and outputting the adjusting instruction to the pulse control unit;
the basic characteristics of the cells collected by the cell characteristic pre-collecting unit comprise cell membrane thickness, cytoplasm thickness, cell nucleus membrane thickness and cell nucleus cytoplasm thickness;
the output parameters of the pulse generator collected by the pulse parameter acquisition unit comprise pulse width;
the cell therapy characteristics in the therapy process acquired by the cell therapy parameter acquisition unit comprise a cell membrane potential value, cell membrane conductivity and a perforation aperture;
the cell characteristic preprocessing unit is configured with a cell characteristic preprocessing strategy, and the cell characteristic preprocessing strategy comprises the following steps: substituting the cell membrane thickness, the cytoplasm thickness, the cell nucleus membrane thickness and the cell nucleus cytoplasm thickness into a pulse basic formula to obtain a pulse basic parameter value;
outputting the pulse basic parameter value to a pulse control unit;
the pulse basis formula is configured to: mjc ═ k1 × Hxm × 2+ k2 × Hxz × 2+ k3 × Hxhm × 2+ k4 × Hxhz) α
Wherein Mjc is a pulse basic parameter value, Hxm is a cell membrane thickness, Hxz is a cytoplasm thickness, Hxhm is a cell nucleus membrane thickness, Hxhz is a cell nucleus cytoplasm thickness, k1 is a cell membrane parameter ratio value, k2 is a cytoplasm parameter ratio value, k3 is a cell nucleus membrane parameter ratio value, k4 is a cell nucleus cytoplasm parameter ratio value, and alpha is a cell basic characteristic pulse conversion coefficient;
the cell change processing unit is configured with a cell change processing strategy comprising: acquiring data acquired by the cell therapy parameter acquisition unit once every first change time;
introducing the obtained cell membrane potential value, cell membrane conductivity and perforation aperture of the first change times, and cell membrane thickness, cytoplasm thickness, cell nucleus membrane thickness and cell nucleus cytoplasm thickness into a cell change formula to obtain a cell change reference value;
outputting the cell change reference value to an adjusting unit;
the cellular change formula is configured to:
Figure FDA0003684858300000021
wherein Cbh is a cell change reference value, i is a first change number, a Dxm1 value Dxmi is a cell membrane potential value obtained from the first time within the first change number to a cell membrane potential value obtained from the ith time, Dxm1 to Dxm is a cell membrane conductivity obtained from the first time within the first change number to a cell membrane conductivity obtained from the ith time, Jc1 to Jci are a perforation aperture obtained from the first time within the first change number to a perforation aperture obtained from the ith time, l1 is a reference ratio value of the cell membrane potential value, l2 is a reference ratio value of the cell membrane conductivity, and l3 is a reference ratio value of the perforation aperture;
the adjusting unit is configured with an adjusting strategy, which includes: obtaining a pulse parameter adjustment value by substituting the pulse width, the pulse basic parameter value, the cell change reference value and a pulse adjustment formula;
outputting the pulse parameter adjustment value to a pulse control unit;
the pulse adjustment formula is configured to:
Figure FDA0003684858300000022
wherein, Mct is the pulse parameter adjustment value, Mk is the pulse width, beta is the pulse conversion ratio, and lambda is the cell change compensation coefficient.
The cell characteristic pre-acquisition unit can acquire cell basic characteristics before treatment, the pulse parameter acquisition unit can acquire output parameters of the pulse generator in the treatment process, and the cell treatment parameter acquisition unit can acquire cell treatment characteristics in the treatment process; then, the cell characteristic preprocessing unit is used for processing the cell basic characteristics to obtain pulse basic parameters, and the obtained pulse basic parameters are output to the pulse control unit; the cell change processing unit can process the acquired cell basic characteristics and cell treatment characteristics to obtain a cell change result; the cell change result and the output parameter of the pulse generator can be processed by the adjusting unit to obtain an adjusting result, the adjusting result is converted into an adjusting instruction to be output to the pulse control unit, and the bipolar pulse generator is controlled to operate by the pulse control unit again.
CN202111607045.1A 2021-12-27 2021-12-27 High-frequency bipolar unrecoverable electroporation system Active CN114305659B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111607045.1A CN114305659B (en) 2021-12-27 2021-12-27 High-frequency bipolar unrecoverable electroporation system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111607045.1A CN114305659B (en) 2021-12-27 2021-12-27 High-frequency bipolar unrecoverable electroporation system

Publications (2)

Publication Number Publication Date
CN114305659A CN114305659A (en) 2022-04-12
CN114305659B true CN114305659B (en) 2022-07-26

Family

ID=81013858

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111607045.1A Active CN114305659B (en) 2021-12-27 2021-12-27 High-frequency bipolar unrecoverable electroporation system

Country Status (1)

Country Link
CN (1) CN114305659B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109661210A (en) * 2016-07-12 2019-04-19 上海睿刀医疗科技有限公司 Irreversible electroporation device and its operating method
CN215084247U (en) * 2021-03-29 2021-12-10 中国信息通信研究院 Electroporation control parameter acquisition device, electroporation control device and system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10238447B2 (en) * 2008-04-29 2019-03-26 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
CN112807074A (en) * 2014-05-12 2021-05-18 弗吉尼亚暨州立大学知识产权公司 Electroporation system

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109661210A (en) * 2016-07-12 2019-04-19 上海睿刀医疗科技有限公司 Irreversible electroporation device and its operating method
CN215084247U (en) * 2021-03-29 2021-12-10 中国信息通信研究院 Electroporation control parameter acquisition device, electroporation control device and system

Also Published As

Publication number Publication date
CN114305659A (en) 2022-04-12

Similar Documents

Publication Publication Date Title
CN102736661B (en) MPPT control method in novel photovoltaic system
CN103346692B (en) Frequency domain compensation method for piezoelectric actuator hysteresis nonlinearity in vibration active control
CN113285624B (en) Active damping high-frequency resonance suppression method
CN110247434B (en) Virtual synchronous motor self-inertia adjustment-based grid-connected control method and system
CN1951318A (en) Method and apparatus for inhibiting power frequency common-mode interference
DE102008038314A1 (en) An electrosurgical generator for treating a biological tissue, a method for controlling an output voltage of an electrosurgical generator, and corresponding use of the ESR
CN114305659B (en) High-frequency bipolar unrecoverable electroporation system
CN104020437A (en) Electric energy meter correction method
CN106130495A (en) A kind of collection of simulant signal system and acquisition method
CN104079193A (en) Device for direct current component adjustment and control method thereof
CN202075343U (en) Three phase electric energy meter and three phase electric energy correction system
CN107179519A (en) A kind of passage calibrating installation and method for digital oscilloscope
CN112986775A (en) Active calibration method for partial discharge pulse phase
CN107529270A (en) The microwave driving source with self-fixed amplitude technique of high energy accelerator for electron therapy
CN112255457A (en) Phase angle difference measuring method suitable for automatic quasi-synchronization device
CN112036010A (en) Photovoltaic system dynamic process hybrid equivalent modeling method based on data driving
CN105896591B (en) Photovoltaic combining inverter self-adaptation control method
CN102649003B (en) Based on the constant current stimulation circuit that EMG feedback stimulates
CN101262131A (en) A mixed active power filter with online adjustable controller parameter
CN206960755U (en) The filtering apparatus of solar simulator
CN205850003U (en) A kind of SCM Based myoelectricity boost pulse instrument
CN106208130B (en) A kind of three-phase grid-connected inverter robust control method based on adaptive constrained optimization
CN115089874A (en) Self-adaptive micro-current electrotherapy system based on brain wave feedback
DE102020002335B4 (en) Process to improve the ohmic contact behavior between a contact grid and an emitter layer of a silicon solar cell
CN106708781B (en) Photovoltaic power station flicker level measurement method and device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant